Professional overview
Kang Zengshou is a Chief Physician and Professor in the Department of Nuclear Medicine at Peking Union Medical College Hospital, specializing in radionuclide therapy for thyroid disorders and other conditions.
Areas of focus
Clinic days
From the hospital website, checked 2026-11-19. Schedules change, so check before you go.
Background
- 1964Graduated from the Medical Department of Harbin Medical University
Experience & recognition
- Treated nearly 20,000 cases of Graves' and Plummer's hyperthyroidism with iodine-131
- Treated over 500 cases of polycythemia vera, thoracoabdominal metastatic tumors, hemophilic joint hemorrhage, bone pain from cancer bone metastases, and thyroid cancer with radionuclides
- Developed a new I-131 therapy EHL measurement method that improved work efficiency fourfold
- Contributed to over 10 major publications including Endocrinology, Nuclear Medicine, and Radiobiology
- Published over 50 papers
- Standing Committee Member of the Asian Journal of Nuclear Medicine
Professional roles
- Standing Committee Member, Asian Journal of Nuclear Medicine
- Expert, Medical Accident Appraisal Committee, Chinese Medical Association (CMA)
Frequently asked questions
What does Dr. Kang Zengshou specialize in?
Specializes in radionuclide therapy for Graves' disease, pediatric Graves' hyperthyroidism, polycythemia vera, thoracoabdominal metastatic tumors, hemophilic joint hemorrhage, bone pain from cancer bone metastases, and thyroid cancer.
Which hospital and department is Dr. Kang Zengshou in?
Department of Nuclear Medicine at Peking Union Medical College Hospital
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Kang Zengshou has not reviewed this page.
